Anti-SNX13 monoclonal antibody
Pre-made anti-SNX13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SNX13/SNX13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1783-Ab-1/ GM-Tg-hg-IP1783-Ab-2 | Anti-Human SNX13 monoclonal antibody | Human |
GM-Tg-rg-IP1783-Ab-1/ GM-Tg-rg-IP1783-Ab-2 | Anti-Rat SNX13 monoclonal antibody | Rat |
GM-Tg-mg-IP1783-Ab-1/ GM-Tg-mg-IP1783-Ab-2 | Anti-Mouse SNX13 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1783-Ab-1/ GM-Tg-cynog-IP1783-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SNX13 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1783-Ab-1/ GM-Tg-felg-IP1783-Ab-2 | Anti-Feline SNX13 monoclonal antibody | Feline |
GM-Tg-cang-IP1783-Ab-1/ GM-Tg-cang-IP1783-Ab-2 | Anti-Canine SNX13 monoclonal antibody | Canine |
GM-Tg-bovg-IP1783-Ab-1/ GM-Tg-bovg-IP1783-Ab-2 | Anti-Bovine SNX13 monoclonal antibody | Bovine |
GM-Tg-equg-IP1783-Ab-1/ GM-Tg-equg-IP1783-Ab-2 | Anti-Equine SNX13 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1783-Ab-1/ GM-Tg-hg-IP1783-Ab-2; GM-Tg-rg-IP1783-Ab-1/ GM-Tg-rg-IP1783-Ab-2; GM-Tg-mg-IP1783-Ab-1/ GM-Tg-mg-IP1783-Ab-2; GM-Tg-cynog-IP1783-Ab-1/ GM-Tg-cynog-IP1783-Ab-2; GM-Tg-felg-IP1783-Ab-1/ GM-Tg-felg-IP1783-Ab-2; GM-Tg-cang-IP1783-Ab-1/ GM-Tg-cang-IP1783-Ab-2; GM-Tg-bovg-IP1783-Ab-1/ GM-Tg-bovg-IP1783-Ab-2; GM-Tg-equg-IP1783-Ab-1/ GM-Tg-equg-IP1783-Ab-2 |
Products Name | Anti-SNX13 monoclonal antibody |
Format | mab |
Target Name | SNX13 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SNX13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1783-Ag-1 | Recombinant multi-species SNX13/ RGS-PX1 protein |
Target information
Target ID | GM-IP1783 |
Target Name | SNX13 |
Gene ID | 23161,217463,362731,714019,475252,101085193,532001,100066218 |
Gene Symbol and Synonyms | mKIAA0713,RGS-PX1,SNX13 |
Uniprot Accession | Q9Y5W8 |
Uniprot Entry Name | SNX13_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000071189 |
Target Classification | N/A |
The target: SNX13, gene name: SNX13, also named as RGS-PX1. This gene encodes a PHOX domain- and RGS domain-containing protein that belongs to the sorting nexin (SNX) family and the regulator of G protein signaling (RGS) family. The PHOX domain is a phosphoinositide binding domain, and the SNX family members are involved in intracellular trafficking. The RGS family members are regulatory molecules that act as GTPase activating proteins for G alpha subunits of heterotrimeric G proteins. The RGS domain of this protein interacts with G alpha(s), accelerates its GTP hydrolysis, and attenuates G alpha(s)-mediated signaling. Overexpression of this protein delayes lysosomal degradation of the epidermal growth factor receptor. Because of its bifunctional role, this protein may link heterotrimeric G protein signaling and vesicular trafficking. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.